Home
/ IDS
/ Competitors

IDS Competitors and Similar CompaniesClear all

IDS's competitors and similar companies include Abaxis, Autobio Diagnostics, Transasia Bio-Medicals and Allengers Medical Systems.

	IDS IDS (also known as Immunodiagnostic Systems Holdings) is a medical diagnostics business that develops and provides automated and manual assays.	Abaxis Abaxis is a provider of medical and veterinary diagnostics solutions.	Autobio Diagnostics Autobio Diagnostics (奧託生物診斷有限公司) is a manufacturer and supplier of medical diagnostics products.	Transasia Bio-Medicals Transasia Bio-Medicals is a developer and manufacturer of healthcare products.	Allengers Medical Systems Allengers Medical Systems is a manufacturer and supplier of medical diagnostic equipment.
Founding Date	Founding Date 1977	Founding Date 1995	Founding Date 1998	Founding Date 1979	Founding Date 1987
Type	Type Subsidiary	Type Subsidiary	Type Public	Type Subsidiary	Type Private
Tags	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics
Locations	Locations Boldon Colliery, GB HQ Liège, BE Markham, CA Kralupy Nad Vltavou, CZ København, DK Paris, FR see more	Locations Union City, US HQ Griesheim, DE Hong Kong, HK	Locations Zheng Zhou Shi, CN HQ	Locations HQ	Locations HQ
Employees	Employees 276	Employees 281	Employees 5,773	Employees 2,0351% increase	Employees 961
Financial
Revenue (est.)	Revenue (est.) £39.3m (FY, 2020)	Revenue (est.) $244.7m (FY, 2018)	Revenue (est.) ¥4.1b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods £17.2m (FY, 2020)	Cost of goods $111.1m (FY, 2018)	Cost of goods ¥1.5b (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit £22.1m (FY, 2020)	Gross profit $133.6m (FY, 2018)	Gross profit ¥2.7b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income £3.3m (FY, 2020)	Net income $27.2m (FY, 2018)	Net income ¥1.1b (FY, 2025)	Net income N/A	Net income N/A